# Future Health
Statement of investments and other net assets as at 31.10.2023
| Description | % | Expiry/  Currency	Initial holding | Purchases* | Sales* | Closing holding | Market value in | % of |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  |  | Maturity	on 01.05.2023 |  |  | on 31.10.2023 | USD | net assets |

Transferable securities admitted to an official stock exchange listing
| Shares |  |
| --- | --- |
| Abbott Laboratories Inc | USD | 59 636 | 6 668 | - | 66 304 | 6 269 043.20 | 3.69 |
| Align Technology Inc | USD | - | 8 000 | -1 424 | 6 576 | 1 213 863.84 | 0.71 |
| Alnylam Pharmaceuticals Inc | USD | - | 6 871 | - | 6 871 | 1 043 017.80 | 0.61 |
| Alphatec Holdings Inc | USD | 312 482 | 117 463 | - | 429 945 | 3 946 895.10 | 2.32 |
| Amgen Inc | USD | 10 770 | - | -10 770 | - | - | 0.00 |
| Apellis Pharmaceuticals Inc | USD | 21 336 | 126 185 | -30 633 | 116 888 | 5 687 770.08 | 3.35 |
| Arcutis Biother Rg | USD | 319 896 | 338 891 | -266 859 | 391 928 | 881 838.00 | 0.52 |
| Argen-X N.V. | EUR | 7 025 | - | - | 7 025 | 3 297 631.24 | 1.94 |
| Astellas Pharma Inc | JPY | - | 226 420 | -70 300 | 156 120 | 1 958 652.48 | 1.16 |
| Astrazeneca Plc | GBP | 60 804 | - | -26 627 | 34 177 | 4 250 888.27 | 2.50 |
| Bachem Hldg N | CHF | 28 216 | - | -28 216 | - | - | 0.00 |
| Basilea Pharmaceutica /Nam.Akt | CHF | 78 987 | - | -5 622 | 73 365 | 2 845 761.39 | 1.68 |
| Bavarian Nordic | DKK | 221 199 | - | - | 221 199 | 4 205 423.89 | 2.48 |
| Beigene Ltd /Adr | USD | 33 782 | 5 262 | -39 044 | - | - | 0.00 |
| Biogen Inc | USD | 44 070 | 5 270 | -21 333 | 28 007 | 6 652 782.78 | 3.92 |
| Biomarin Pharmaceutical Inc | USD | 80 937 | - | -10 321 | 70 616 | 5 751 673.20 | 3.39 |
| Boston Scientific Corp. | USD | 155 048 | - | - | 155 048 | 7 936 907.12 | 4.67 |
| Bristol Myers Squibb Co | USD | 75 440 | - | -75 440 | - | - | 0.00 |
| Daiichi Sankyo Co Ltd | JPY | 65 400 | - | -65 400 | - | - | 0.00 |
| Danaher Corp | USD | - | 13 985 | -5 901 | 8 084 | 1 552 289.68 | 0.91 |
| Dexcom Inc | USD | 33 532 | 18 147 | - | 51 679 | 4 590 645.57 | 2.70 |
| Eisai Co.Ltd | JPY | 204 100 | - | -146 500 | 57 600 | 3 027 856.93 | 1.78 |
| Euroapi | EUR | 223 846 | - | -223 846 | - | - | 0.00 |
| Fresenius Se & Co Kgaa | EUR | - | 193 352 | - | 193 352 | 4 954 003.07 | 2.92 |
| Gilead Sciences Inc. | USD | 47 108 | 52 808 | - | 99 916 | 7 847 402.64 | 4.62 |
| Globus Medical Inc -A- | USD | 155 156 | 27 905 | -54 709 | 128 352 | 5 866 969.92 | 3.46 |
| Gsk Plc | GBP | 316 950 | - | -316 950 | - | - | 0.00 |
| Hologic Inc | USD | 63 273 | 34 149 | -36 466 | 60 956 | 4 033 458.52 | 2.38 |
| Humana Inc. | USD | - | 10 900 | - | 10 900 | 5 708 221.00 | 3.36 |
| Incyte Corporation | USD | 68 516 | - | -68 516 | - | - | 0.00 |
| Intra-Cellular Therapies Inc | USD | 91 317 | 43 561 | -49 949 | 84 929 | 4 226 067.04 | 2.49 |
| Iqvia Holdings Inc | USD | 26 997 | 18 351 | -20 323 | 25 025 | 4 525 270.75 | 2.67 |
| Lilly (Eli) & Co | USD | 22 699 | - | -2 722 | 19 977 | 11 065 859.61 | 6.52 |
| Madrigal Pharmaceuticals Inc | USD | 7 562 | 23 534 | -11 187 | 19 909 | 2 615 644.42 | 1.54 |
| Medtronic Holdings Limited | USD | - | 28 837 | - | 28 837 | 2 034 738.72 | 1.20 |
| Microsoft Corp | USD | - | 14 456 | - | 14 456 | 4 887 718.16 | 2.88 |
| Moderna Inc | USD | - | 17 793 | - | 17 793 | 1 351 556.28 | 0.80 |
| Novo Nordisk A/S B | DKK | - | 21 104 | -21 104 | - | - | 0.00 |
| Novo Nordisk As -B- | DKK | - | 42 208 | -19 799 | 22 409 | 2 148 441.18 | 1.26 |
| Orion Corp (New)- Shs -B- | EUR | - | 75 785 | - | 75 785 | 3 007 132.13 | 1.77 |
| Pfizer Inc. | USD | - | 99 600 | - | 99 600 | 3 043 776.00 | 1.79 |
| Phreesia Inc | USD | - | 169 104 | -169 104 | - | - | 0.00 |
| Qiagen N.V. | EUR | 89 048 | - | -89 048 | - | - | 0.00 |
| Quest Diagnostics Inc. | USD | - | 29 498 | -29 498 | - | - | 0.00 |
| Roche Holding Ag /Genussschein | CHF | 26 339 | - | -8 949 | 17 390 | 4 468 603.40 | 2.63 |
| Sage Therapeutics Inc | USD | 56 298 | 57 596 | -113 894 | - | - | 0.00 |
| Sanofi | EUR | 91 958 | - | - | 91 958 | 8 330 006.23 | 4.91 |
| Sarepta Therapeutics Inc | USD | 32 405 | 28 387 | -41 791 | 19 001 | 1 278 957.31 | 0.75 |
| Sartorius Ag /Vorzug. | EUR | 10 696 | - | -10 696 | - | - | 0.00 |
| Seagen Rg | USD | 13 004 | - | -13 004 | - | - | 0.00 |
| Siemens Healthineers Ag | EUR | 21 393 | 34 442 | -22 183 | 33 652 | 1 647 610.00 | 0.97 |
| Smith And Nephew Plc | GBP | 260 313 | 143 330 | -246 672 | 156 971 | 1 753 907.25 | 1.03 |
| Surgery Partners Inc | USD | - | 181 068 | -79 369 | 101 699 | 2 352 297.87 | 1.39 |
| Sysmex Corp. Kobe | JPY | 44 700 | 29 800 | -74 500 | - | - | 0.00 |
| Tenet Healthcare | USD | 60 288 | 66 308 | -126 596 | - | - | 0.00 |

* Purchases and sales (unaudited) include the following transactions:
Exercising of subscription/option rights/conversions/name changes/stock splits/transfers/switching between companies/free units/purchases/splits/stock/elective dividends/exit following expiry/drawing of lots/reverse splits/redemptions/disposals.

Translation (ENDE, 2023-10-31):
# Future Health
Wertpapierbestand und sonstige Vermögenswerte per 31.10.2023
| Bezeichnung | % | Verfall/ | Währung | Anfangs- | Käufe* | Verkäufe* | Schluss- | Marktwert | % des |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  | Fälligkeit |  | bestand |  |  | bestand | in | Netto- |
|  |  |  |  | 01.05.2023 |  |  | 31.10.2023 | USD | vermögens |

Übertragbare Wertpapiere, die an einer amtlichen Börse zugelassen sind
| Aktien |  |
| --- | --- |
| Abbott Laboratories Inc | USD | 59 636 | 6 668 | - | 66 304 | 6 269 043.20 | 3.69 |
| Align Technology Inc | USD | - | 8 000 | -1 424 | 6 576 | 1 213 863.84 | 0.71 |
| Alnylam Pharmaceuticals Inc | USD | - | 6 871 | - | 6 871 | 1 043 017.80 | 0.61 |
| Alphatec Holdings Inc | USD | 312 482 | 117 463 | - | 429 945 | 3 946 895.10 | 2.32 |
| Amgen Inc | USD | 10 770 | - | -10 770 | - | - | 0.00 |
| Apellis Pharmaceuticals Inc | USD | 21 336 | 126 185 | -30 633 | 116 888 | 5 687 770.08 | 3.35 |
| Arcutis Biother Rg | USD | 319 896 | 338 891 | -266 859 | 391 928 | 881 838.00 | 0.52 |
| Argen-X N.V. | EUR | 7 025 | - | - | 7 025 | 3 297 631.24 | 1.94 |
| Astellas Pharma Inc | JPY | - | 226 420 | -70 300 | 156 120 | 1 958 652.48 | 1.16 |
| Astrazeneca Plc | GBP | 60 804 | - | -26 627 | 34 177 | 4 250 888.27 | 2.50 |
| Bachem Hldg N | CHF | 28 216 | - | -28 216 | - | - | 0.00 |
| Basilea Pharmaceutica /Nam.Akt | CHF | 78 987 | - | -5 622 | 73 365 | 2 845 761.39 | 1.68 |
| Bavarian Nordic | DKK | 221 199 | - | - | 221 199 | 4 205 423.89 | 2.48 |
| Beigene Ltd /Adr | USD | 33 782 | 5 262 | -39 044 | - | - | 0.00 |
| Biogen Inc | USD | 44 070 | 5 270 | -21 333 | 28 007 | 6 652 782.78 | 3.92 |
| Biomarin Pharmaceutical Inc | USD | 80 937 | - | -10 321 | 70 616 | 5 751 673.20 | 3.39 |
| Boston Scientific Corp. | USD | 155 048 | - | - | 155 048 | 7 936 907.12 | 4.67 |
| Bristol Myers Squibb Co | USD | 75 440 | - | -75 440 | - | - | 0.00 |
| Daiichi Sankyo Co Ltd | JPY | 65 400 | - | -65 400 | - | - | 0.00 |
| Danaher Corp | USD | - | 13 985 | -5 901 | 8 084 | 1 552 289.68 | 0.91 |
| Dexcom Inc | USD | 33 532 | 18 147 | - | 51 679 | 4 590 645.57 | 2.70 |
| Eisai Co.Ltd | JPY | 204 100 | - | -146 500 | 57 600 | 3 027 856.93 | 1.78 |
| Euroapi | EUR | 223 846 | - | -223 846 | - | - | 0.00 |
| Fresenius Se & Co Kgaa | EUR | - | 193 352 | - | 193 352 | 4 954 003.07 | 2.92 |
| Gilead Sciences Inc. | USD | 47 108 | 52 808 | - | 99 916 | 7 847 402.64 | 4.62 |
| Globus Medical Inc -A- | USD | 155 156 | 27 905 | -54 709 | 128 352 | 5 866 969.92 | 3.46 |
| Gsk Plc | GBP | 316 950 | - | -316 950 | - | - | 0.00 |
| Hologic Inc | USD | 63 273 | 34 149 | -36 466 | 60 956 | 4 033 458.52 | 2.38 |
| Humana Inc. | USD | - | 10 900 | - | 10 900 | 5 708 221.00 | 3.36 |
| Incyte Corporation | USD | 68 516 | - | -68 516 | - | - | 0.00 |
| Intra-Cellular Therapies Inc | USD | 91 317 | 43 561 | -49 949 | 84 929 | 4 226 067.04 | 2.49 |
| Iqvia Holdings Inc | USD | 26 997 | 18 351 | -20 323 | 25 025 | 4 525 270.75 | 2.67 |
| Lilly (Eli) & Co | USD | 22 699 | - | -2 722 | 19 977 | 11 065 859.61 | 6.52 |
| Madrigal Pharmaceuticals Inc | USD | 7 562 | 23 534 | -11 187 | 19 909 | 2 615 644.42 | 1.54 |
| Medtronic Holdings Limited | USD | - | 28 837 | - | 28 837 | 2 034 738.72 | 1.20 |
| Microsoft Corp | USD | - | 14 456 | - | 14 456 | 4 887 718.16 | 2.88 |
| Moderna Inc | USD | - | 17 793 | - | 17 793 | 1 351 556.28 | 0.80 |
| Novo Nordisk A/S B | DKK | - | 21 104 | -21 104 | - | - | 0.00 |
| Novo Nordisk As -B- | DKK | - | 42 208 | -19 799 | 22 409 | 2 148 441.18 | 1.26 |
| Orion Corp (New)- Shs -B- | EUR | - | 75 785 | - | 75 785 | 3 007 132.13 | 1.77 |
| Pfizer Inc. | USD | - | 99 600 | - | 99 600 | 3 043 776.00 | 1.79 |
| Phreesia Inc | USD | - | 169 104 | -169 104 | - | - | 0.00 |
| Qiagen N.V. | EUR | 89 048 | - | -89 048 | - | - | 0.00 |
| Quest Diagnostics Inc. | USD | - | 29 498 | -29 498 | - | - | 0.00 |
| Roche Holding Ag /Genussschein | CHF | 26 339 | - | -8 949 | 17 390 | 4 468 603.40 | 2.63 |
| Sage Therapeutics Inc | USD | 56 298 | 57 596 | -113 894 | - | - | 0.00 |
| Sanofi | EUR | 91 958 | - | - | 91 958 | 8 330 006.23 | 4.91 |
| Sarepta Therapeutics Inc | USD | 32 405 | 28 387 | -41 791 | 19 001 | 1 278 957.31 | 0.75 |
| Sartorius Ag /Vorzug. | EUR | 10 696 | - | -10 696 | - | - | 0.00 |
| Seagen Rg | USD | 13 004 | - | -13 004 | - | - | 0.00 |
| Siemens Healthineers Ag | EUR | 21 393 | 34 442 | -22 183 | 33 652 | 1 647 610.00 | 0.97 |
| Smith And Nephew Plc | GBP | 260 313 | 143 330 | -246 672 | 156 971 | 1 753 907.25 | 1.03 |
| Surgery Partners Inc | USD | - | 181 068 | -79 369 | 101 699 | 2 352 297.87 | 1.39 |
| Sysmex Corp. Kobe | JPY | 44 700 | 29 800 | -74 500 | - | - | 0.00 |

* Käufe und Verkäufe (ungeprüft) umfassen die folgenden Transaktionen:
Ausübung von Bezugs-/Optionsrechten/Umwandlungen/Namensänderungen/Titelaufteilungen/Übertragungen/Umtausch zwischen Gesellschaften/Gratisanteile/Käufe/„Splits“/Aktien-/Wahldividenden/Ausgang infolge Verfall/Auslosungen/„Reversesplits“/Rückzahlungen/Verkäufe